In Brief: J&J v. Millenson
This article was originally published in The Tan Sheet
Executive Summary
J&J v. Millenson: Arbitrator determines Johnson & Johnson's premarket submission in France violated a milestone payment agreement in former Direct Access Diagnostic President and CEO Eliot Millenson's contract. Under the decision, J&J agrees to pay Millenson $500,000 for his role in developing the Confide home HIV test system. Millenson and J&J also are involved in ongoing litigation in New Jersey Superior Court over ownership of Direct Access ("The Tan Sheet" Aug. 5, p. 4). A court date to determine whether J&J will have to relinquish all Direct Access assets to Millenson has been set for Oct. 16...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning